Sunflower Pharmaceutical Group Co.,Ltd

Shenzhen Stock Exchange 002737.SZ

Sunflower Pharmaceutical Group Co.,Ltd Price to Book Ratio (P/B) on January 14, 2025: 2.35

Sunflower Pharmaceutical Group Co.,Ltd Price to Book Ratio (P/B) is 2.35 on January 14, 2025, a -23.45% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Sunflower Pharmaceutical Group Co.,Ltd 52-week high Price to Book Ratio (P/B) is 3.65 on May 14, 2024, which is 55.06% above the current Price to Book Ratio (P/B).
Sunflower Pharmaceutical Group Co.,Ltd 52-week low Price to Book Ratio (P/B) is 2.27 on September 13, 2024, which is -3.73% below the current Price to Book Ratio (P/B).
Sunflower Pharmaceutical Group Co.,Ltd average Price to Book Ratio (P/B) for the last 52 weeks is 2.86.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002737.SZ

Sunflower Pharmaceutical Group Co.,Ltd

CEO	Ms. Yi Guan
IPO Date	Dec. 30, 2014
Location	China
Headquarters	Concentrated Area, Yingbin Road
Employees	5,776
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Sunflower Pharmaceutical Group Co.,Ltd researches, develops, manufactures, and markets Chinese patent medicines in China. The company also produces chemical, biological, and health care medicines. Its products are used in therapeutic areas, such as pediatrics, gynecology, digestive system, respiratory and cold, rheumatism and bone disease, and cardiovascular and cerebrovascular. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is based in Harbin, China.

Key trends

Past 5 years